Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymol (2-isopropyl-5-methylphenol) is a naturally occurring monoterpene phenol found primarily in the essential oil of Thymus vulgaris (PubChem CID 6989). It is not a biological target itself, but rather a bioactive small molecule that acts as a ligand for several physiological receptors and ion channels. Pharmacologically, thymol is recognized as a positive allosteric modulator of the Gamma-aminobutyric acid type A (GABA-A) receptor, which mediates its sedative and anesthetic-like effects (Priestley et al., 2003). It also functions as an agonist for the Transient Receptor Potential Vanilloid 3 (TRPV3) and Ankyrin 1 (TRPA1) ion channels, contributing to its roles in thermosensation and pain modulation (Xu et al., 2006). Beyond mammalian targets, thymol exhibits potent broad-spectrum antimicrobial and antifungal properties by physically disrupting microbial cell membranes and inducing the leakage of vital intracellular components (García-Salinas et al., 2018). Due to these diverse actions, it is a common active ingredient in antiseptic mouthwashes, topical disinfectants, and various over-the-counter pharmaceutical preparations. Its anti-inflammatory and antioxidant activities further support its use in treating oral diseases and minor skin irritations. As a small molecule compound, thymol is classified as a drug or active pharmaceutical ingredient rather than a therapeutic target protein.
Thymol exerts its effects through multiple mechanisms: it acts as a positive allosteric modulator of GABA-A receptors to increase chloride ion conductance (Priestley et al., 2003); it activates TRPV3 and TRPA1 ion channels involved in sensory signaling (Xu et al., 2006); and it disrupts the lipid bilayer of microbial cell membranes, leading to cell lysis (García-Salinas et al., 2018).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymol.